CA Stock MarketDetailed Quotes

MYCO Mydecine Innovations Group Inc

Watchlist
  • 0.010
  • 0.0000.00%
15min DelayMarket Closed May 7 09:30 ET
617.55KMarket Cap-0.05P/E (TTM)

About Mydecine Innovations Group Inc Company

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Company Profile

SymbolMYCO
Company NameMydecine Innovations Group Inc
Founded2013
MarketCNQ
Employees3
Fiscal Year Ends12-31
Address1890 – 1075 West Georgia Street Suite 810
CityVancouver
CountryCAN
Zip CodeV6E 3C9
Phone+1 888 871-393

Company Executives

  • Name
  • Position
  • Salary
  • David Joshua Bartch
  • Director and Chief Executive Officer
  • --
  • Robert Roscow
  • Director and Chief Scientific Officer
  • --
  • Dr. Rakesh Jetly
  • Chief Medical Officer
  • --
  • Dean Ditto
  • Chief Financial Officer
  • --
  • Damon Michaels
  • Director and Chief Operating Officer
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More